prod:prod_dcx-login
Xpert® Bladder Cancer Detection
Detection of the presence of bladder cancer in patients with hematuria in around 90 minutes
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
10 Tests
GXBLAD-CD-CE-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support
The Need
Early and accurate diagnosis of bladder cancer is critical in patients with hematuria.3
- Four out of five people with bladder cancer have blood in their urine4
- But 80–90% of patients with visible hematuria, and over 95% of patients with non-visible hematuria do NOT have cancer
- There are many known causes of hematuria including urinary tract infection, nephrolitiasis (stones), etc4
- In patients with hematuria, it can be difficult to decide which patients might have cancer and which patients might have a different condition
- Primary care physicians are sometimes reluctant to refer patients with visible or significant microscopic hematuria to urology for further investigation5
3 Kamat AM, et al. Bladder Cancer. Lancet. 2016 Dec 3;388(10061):2796-2810.
4 Avellino G, et al. Diagnosis and Management of hematuria. Surg Clin North Am. 2016 Jun;96(3): 503-15.
5 Yafi FA, et al. Patients with microscopic and gross hematuria: practice and referral patterns among primary care physicians in a universal health care system. Can Urol Assoc J 2011;5(2):97-101.
4 Avellino G, et al. Diagnosis and Management of hematuria. Surg Clin North Am. 2016 Jun;96(3): 503-15.
5 Yafi FA, et al. Patients with microscopic and gross hematuria: practice and referral patterns among primary care physicians in a universal health care system. Can Urol Assoc J 2011;5(2):97-101.
The Solution
Xpert Bladder Cancer Detection is a non-invasive biomarker test for patients with hematuria that is used in conjunction with other clinical measures.
- Five mRNA biomarkers were intensively validated for the detection of bladder cancer
- The non-invasive and painless test uses voided urine samples
- The test is performed using a self-contained cartridge and system, and can be performed in any size urology lab
- Each cartridge contains three controls for dependable results
- Sample stability for up to 7 days in Xpert® Urine Transport Reagent
- The test enables flexible testing as require
The Impact
A test that helps clinicians gain additional information for patients with hematuria.
- Non-invasive test to reduce patients’ anxiety, pain, and embarrassment6
- High negative predictive value may help patients avoid unnecessary procedures and discomfort7
- Easy to implement and train
- Robust test and workflow with decentralized laboratory testing
6 Biardeau X, et al. Prospective evaluation of anxiety, pain, and embarrassment associated with cystoscopy and urodynamic testing in clinical practice. Can Urol Assoc J. 2017 Mar-Apr; 11(3-4): 104–110.
7 Todenhöfer, et al. Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer. BMC Cancer. 2015 Mar 19;15:155.
7 Todenhöfer, et al. Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer. BMC Cancer. 2015 Mar 19;15:155.
Related Products
Xpert BCR-ABL Ultra
Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)
Expert Bladder Cancer Monitor
Qualitative monitoring for recurrence in patients previously diagnosed with bladder cancer in around 90 minutes
Xpert FII & FV
30-Minute Test for Genetic Risk of Thrombosis
Xpert Breast Cancer STRAT4
Standardized breast cancer ESR1/PGR/ERBB2/MKi67 mRNA biomarker assessment in less than two hours